Assignee
GW PHARMA LTD
GB·47 granted patents·49 pending applications·2,011 citations·filing 2001–2022
Top patents by PatentIndex Score
96 records- 0199US10807777B2Pharmaceutical formulationGW PHARMA LTD·Filed 2019·Granted Oct 20, 2020·38 cites·20 claims
- 0298US11311498B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Apr 26, 2022·34 cites·21 claims
- 0398US10765643B2Use of cannabidiol in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Sep 8, 2020·35 cites·15 claims
- 0498US10538373B2Pharmaceutical formulationGW PHARMA LTD·Filed 2019·Granted Jan 21, 2020·11 cites·19 claims
- 0598US10195159B2Processes and apparatus for extraction of active substances and enriched extracts from natural productsGW PHARMA LTD·Filed 2015·Granted Feb 5, 2019·41 cites·5 claims
- 0698US10137095B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Nov 27, 2018·63 cites·8 claims
- 0798US10111840B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Oct 30, 2018·67 cites·14 claims
- 0898US10092525B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Oct 9, 2018·62 cites·8 claims
- 0998US9956185B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·71 cites·11 claims
- 1098US9956186B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·68 cites·11 claims
- 1198US9956183B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·69 cites·18 claims
- 1298US9956184B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·67 cites·12 claims
- 1398US9949937B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Apr 24, 2018·64 cites·14 claims
- 1498US9522123B2Use of one or a combination of phyto-cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2014·Granted Dec 20, 2016·62 cites·13 claims
- 1598US7709536B2Pharmaceutical formulationGW PHARMA LTD·Filed 2005·Granted May 4, 2010·53 cites·10 claims
- 1698US7025992B2Pharmaceutical formulationsGW PHARMA LTD·Filed 2001·Granted Apr 11, 2006·110 cites·38 claims
- 1797US11318109B2Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)GW PHARMA LTD·Filed 2019·Granted May 3, 2022·17 cites·42 claims
- 1897US6946150B2Pharmaceutical formulationGW PHARMA LTD·Filed 2002·Granted Sep 20, 2005·92 cites·26 claims
- 1997US6730330B2Pharmaceutical formulationsGW PHARMA LTD·Filed 2001·Granted May 4, 2004·98 cites·16 claims
- 2096US12121499B2Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)GW PHARMA LTD·Filed 2022·Granted Oct 22, 2024·3 cites·22 claims
- 2196US12023305B2Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsyGW PHARMA LTD·Filed 2020·Granted Jul 2, 2024·9 cites·7 claims
- 2296US10799467B2Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Oct 13, 2020·22 cites·6 claims
- 2396US9949936B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2016·Granted Apr 24, 2018·54 cites·14 claims
- 2496US9474726B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Oct 25, 2016·74 cites·8 claims
- 2596US7622140B2Processes and apparatus for extraction of active substances and enriched extracts from natural productsGW PHARMA LTD·Filed 2002·Granted Nov 24, 2009·107 cites·28 claims
- 2696US7344736B2Extraction of pharmaceutically active components from plant materialsGW PHARMA LTD·Filed 2002·Granted Mar 18, 2008·103 cites·21 claims
- 2795US9962341B2Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancerGW PHARMA LTD·Filed 2015·Granted May 8, 2018·27 cites·9 claims
- 2895US9029423B2Pharmaceutical formulationGW PHARMA LTD·Filed 2013·Granted May 12, 2015·18 cites·4 claims
- 2995US7968594B2Pharmaceutical compositions for the treatment of painGW PHARMA LTD·Filed 2005·Granted Jun 28, 2011·47 cites·12 claims
- 3094US11413266B2Use of cannabinoids in the treatment of inflammatory skin diseasesGW PHARMA LTD·Filed 2016·Granted Aug 16, 2022·15 cites·5 claims
- 3194US10758514B2Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumourGW PHARMA LTD·Filed 2018·Granted Sep 1, 2020·22 cites·7 claims
- 3294US9205063B2Cannabinoid-containing plant extracts as neuroprotective agentsGW PHARMA LTD·Filed 2014·Granted Dec 8, 2015·50 cites·1 claims
- 3393US9675579B2Tetrahydrocannabivarin for use in the treatment of nausea and vomitingGW PHARMA LTD·Filed 2014·Granted Jun 13, 2017·55 cites·12 claims
- 3492US10179683B2Pharmaceutical formulationGW PHARMA LTD·Filed 2015·Granted Jan 15, 2019·8 cites·16 claims
- 3591US10653641B2Use of cannabinoids in the treatment of mental disordersGW PHARMA LTD·Filed 2016·Granted May 19, 2020·15 cites·7 claims
- 3690US9669002B2Use for cannabinoidGW PHARMA LTD·Filed 2015·Granted Jun 6, 2017·13 cites·3 claims
- 3789US9675654B2Phytocannabinoids in the treatment of cancerGW PHARMA LTD·Filed 2014·Granted Jun 13, 2017·17 cites·1 claims
- 3887USD559396SSecure container for holding liquid medicamentsGW PHARMA LTD·Filed 2006·Granted Jan 8, 2008·39 cites·1 claims
- 3986US10039724B27-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD)GW PHARMA LTD·Filed 2015·Granted Aug 7, 2018·15 cites·8 claims
- 4086US8034843B2Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditionsGW PHARMA LTD·Filed 2003·Granted Oct 11, 2011·25 cites·16 claims
- 4186US6929154B2Secure dispensing apparatusGW PHARMA LTD·Filed 2001·Granted Aug 16, 2005·43 cites·22 claims
- 4280US7246724B2Dispenser for receiving a cartridge of material having retractable pinsGW PHARMA LTD·Filed 2003·Granted Jul 24, 2007·28 cites·8 claims
- 4376US7537005B2Dose dispensing system and apparatusGW PHARMA LTD·Filed 2003·Granted May 26, 2009·59 cites·11 claims
- 4475US2020306328A1Extraction of pharmaceutically active components from plant materialsGW PHARMA LTD·Filed 2019·Application pending·0 cites
- 4571US11390437B2Pharmaceutical formulationGW PHARMA LTD·Filed 2020·Granted Jul 19, 2022·0 cites·15 claims
- 4671US2020206151A1Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditionsGW PHARMA LTD·Filed 2019·Application pending·0 cites
- 4769US9421187B2Phytocannabinoids for use in the treatment of intestinal inflammatory diseasesGW PHARMA LTD·Filed 2012·Granted Aug 23, 2016·2 cites·9 claims
- 4869US2021128657A1Extraction of pharmaceutically active components from plant materialsGW PHARMA LTD·Filed 2020·Application pending·0 cites
- 4969US2020206184A1Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritisGW PHARMA LTD·Filed 2019·Application pending·0 cites
- 5068US2019322427A1Pharmaceutical formulationGW PHARMA LTD·Filed 2019·Application pending·0 cites
Showing the top 50 of 96 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →